Predicting amyloid-β levels in amnestic mild cognitive impairment using machine learning techniques
Background: Amyloid-ß positivity (Aß+) based on PET imaging is part of the enrollment
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
[HTML][HTML] Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques
A Ezzati, DJ Harvey, C Habeck, A Golzar… - Journal of Alzheimer's …, 2020 - ncbi.nlm.nih.gov
Background: Amyloid-β positivity (Aβ+) based on PET imaging is part of the enrollment
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques
A Ezzati, DJ Harvey, C Habeck… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Amyloid-β positivity (Aβ+) based on PET imaging is part of the enrollment
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques
… Disease Neuroimaging Initiative - Journal of …, 2020 - einstein.elsevierpure.com
BACKGROUND: Amyloid-β positivity (Aβ+) based on PET imaging is part of the enrollment
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques.
A Ezzati, DJ Harvey, C Habeck, A Golzar… - Journal of Alzheimer's …, 2020 - europepmc.org
Background Amyloid-β positivity (Aβ+) based on PET imaging is part of the enrollment
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques.
A Ezzati, DJ Harvey, C Habeck, A Golzar… - Journal of Alzheimer's …, 2020 - escholarship.org
BackgroundAmyloid-β positivity (Aβ+) based on PET imaging is part of the enrollment
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
criteria for many of the clinical trials of Alzheimer's disease (AD), particularly in trials for …
